Literature DB >> 11443025

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients.

I Bourdel-Marchasson1, M C Delmas-Beauvieux, E Peuchant, S Richard-Harston, A Decamps, B Reignier, J P Emeriau, M Rainfray.   

Abstract

OBJECTIVES: to investigate blood markers of oxidative stress, and enzymatic and non-enzymatic antioxidants in normally nourished elderly people with Alzheimer's disease.
DESIGN: case-control study.
SUBJECTS: twenty patients with Alzheimer's disease and 23 elderly control subjects, living at home, free from disease and not undergoing any treatment known to have a strong influence on blood oxidative stress markers or antioxidant defence systems.
METHODS: we performed a nutritional evaluation, including anthropometric and biological measures and a 3-day dietary record. We determined concentrations of antioxidant vitamins (alpha-tocopherol, retinol) and malondialdehyde in plasma and erythrocytes. We also measured erythrocyte enzymatic activities of glutathione peroxidase and copper-zinc superoxide dismutase.
RESULTS: the two groups were similar in age, body mass index, dietary record and serum albumin concentration. After adjustment for age, sex and cardiovascular co-morbidity, mean plasma concentration of alpha-tocopherol was lower in those with Alzheimer disease than in control subjects (15+/-3.5 mg/l compared with 18.2+/-3.5; P=0.002), as was the mean plasma concentration of retinol (0.54+/-0.2 mg/l vs 0.7+/-0.2; P=0.014). The mean concentration of free plasma malondialdehyde was higher in those with Alzheimer's disease (0.70+/-0.2 mmol/l vs 0.5+/-0.1; P=0.036). In Alzheimer disease patients, free plasma malondialdehyde concentrations were inversely correlated with levels of alpha-tocopherol (P=0.002) and retinol (P=0.025). Erythrocyte levels of vitamins and enzymatic activities were similar in the two groups.
CONCLUSION: lower plasma concentrations of alpha-tocopherol and retinol in normally nourished elderly patients with Alzheimer's disease than in controls could suggest that these antioxidant vitamins had been consumed as a result of excessive production of free radicals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443025     DOI: 10.1093/ageing/30.3.235

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  44 in total

Review 1.  Focus on Pivotal Role of Dietary Intake (Diet and Supplement) and Blood Levels of Tocopherols and Tocotrienols in Obtaining Successful Aging.

Authors:  Mariangela Rondanelli; Milena Anna Faliva; Gabriella Peroni; Francesca Moncaglieri; Vittoria Infantino; Maurizio Naso; Simone Perna
Journal:  Int J Mol Sci       Date:  2015-09-25       Impact factor: 5.923

Review 2.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

Review 3.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 4.  A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease.

Authors:  Fiona E Harrison
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventions.

Authors:  Linnea R Freeman; Jeffrey N Keller
Journal:  Biochim Biophys Acta       Date:  2011-12-20

6.  Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.

Authors:  Claudius Mueller; Matthew Schrag; Andrew Crofton; Jens Stolte; Martina U Muckenthaler; Shino Magaki; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

7.  Plasma carotenoids and tocopherols and cognitive function: a prospective study.

Authors:  Jae Hee Kang; Francine Grodstein
Journal:  Neurobiol Aging       Date:  2007-04-11       Impact factor: 4.673

Review 8.  Vitamin Supplementation as an Adjuvant Treatment for Alzheimer's Disease.

Authors:  Adnan Bashir Bhatti; Muhammad Usman; Farhan Ali; Siddique Akbar Satti
Journal:  J Clin Diagn Res       Date:  2016-08-01

9.  Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.

Authors:  Jason Lockrow; Annamalai Prakasam; Peng Huang; Heather Bimonte-Nelson; Kumar Sambamurti; Ann-Charlotte Granholm
Journal:  Exp Neurol       Date:  2008-12-10       Impact factor: 5.330

10.  Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients.

Authors:  Egidia Costanzi; Sabata Martino; Emanuele Persichetti; Roberto Tiribuzi; Carlo Massini; Giorgio Bernardi; Antonio Orlacchio; Aldo Orlacchio
Journal:  Neurochem Res       Date:  2007-11-28       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.